FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2035732188> ?p ?o ?g. }

• W2035732188 endingPage "411" @default.
• W2035732188 startingPage "406" @default.
• W2035732188 abstract "Designing successful randomized controlled trials (RCTs) in systemic lupus erythematosus (SLE) poses many challenges. It remains difficult to correlate alterations in biologic markers with clinical outcome, especially when signs and symptoms are intermittent and broadly variable between patients. Disease activity indices were not designed specifically as outcome measures in RCTs, as they were developed in the context of longitudinal observational studies. Although all disease activity indices have been validatedagainsteach other and demonstratedto show change, organ system manifestations are variably weighted; fatigue and autoantibodytiters are scored in some and not in others. Due to the variability of the underlying disease course an assessment of disease activity may most accurately be portrayed as change over time, such as an area under the curve analysis. Another lesson learned is that ’responder indices’ proposed in the absence of prospective validation in RCTs do not function well. The argument can always be made that any response criteria will work if the treatment is effective;but without the precedent of a product specifically approved for use in SLE, this is hard to prove. The ACR/Systemic Lupus International Cooperating Clinics (SLICC) damage index was designed to score irreversible manifestations of disease or consequences of its treatment, provided they had been present for at least six months. The damage index may best be utilized to stratify patients or balance randomization at baseline. It may also be incorporated into an endpoint analysis, to ensure that treatment or disease associated deterioration in organ system function (that may be overlooked in scoring disease activity alone) has not occurred. Patient cohort data have demonstrated that the medical outcomes survey short form-36 (SF-36) reflected the effects of SLE better than other patient reported measures. Worsening SF-36 domain scores best correlate with higher disease activity, increased glucocorticoid doses and use of cytotoxic agents. It has been shown sensitive to change in RCTs and observationalcohorts, and reflects the impact of treatment with high dose glucocorticoids and immunosuppressiveagents, as well as end stage renal disease. There is now a body of data derived from RCTs in SLE. Albeit limited, yet to result in an approved therapy, evidence is accumulating that indicate ’early markers’ of response can be defined which may correlate with longer term clinical outcomes. This should inform us in our ongoing efforts to clinically test a broad variety of promising interventions." @default.
• W2035732188 created "2016-06-24" @default.
• W2035732188 creator A5012283576 @default.
• W2035732188 date "2004-05-01" @default.
• W2035732188 modified "2023-10-18" @default.
• W2035732188 title "Clinical trial design in systemic lupus erythematosus: lessons learned and future directions" @default.
• W2035732188 cites W1979972482 @default.
• W2035732188 cites W1983214972 @default.
• W2035732188 cites W1987358421 @default.
• W2035732188 cites W1994092711 @default.
• W2035732188 cites W2009154052 @default.
• W2035732188 cites W2012277169 @default.
• W2035732188 cites W2068833343 @default.
• W2035732188 cites W2068841869 @default.
• W2035732188 cites W2073151750 @default.
• W2035732188 cites W2077028267 @default.
• W2035732188 cites W2078686066 @default.
• W2035732188 cites W2089461179 @default.
• W2035732188 cites W2091679727 @default.
• W2035732188 cites W2103757094 @default.
• W2035732188 cites W2105253459 @default.
• W2035732188 cites W2113059823 @default.
• W2035732188 cites W2135252441 @default.
• W2035732188 cites W2153151218 @default.
• W2035732188 cites W2162112605 @default.
• W2035732188 cites W3123739614 @default.
• W2035732188 cites W4244390464 @default.
• W2035732188 doi "https://doi.org/10.1191/0961203303lu1034oa" @default.
• W2035732188 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15230300" @default.
• W2035732188 hasPublicationYear "2004" @default.
• W2035732188 type Work @default.
• W2035732188 sameAs 2035732188 @default.
• W2035732188 citedByCount "23" @default.
• W2035732188 countsByYear W20357321882012 @default.
• W2035732188 countsByYear W20357321882014 @default.
• W2035732188 countsByYear W20357321882015 @default.
• W2035732188 countsByYear W20357321882021 @default.
• W2035732188 crossrefType "journal-article" @default.
• W2035732188 hasAuthorship W2035732188A5012283576 @default.
• W2035732188 hasConcept C126322002 @default.
• W2035732188 hasConcept C151730666 @default.
• W2035732188 hasConcept C168563851 @default.
• W2035732188 hasConcept C177713679 @default.
• W2035732188 hasConcept C1862650 @default.
• W2035732188 hasConcept C203092338 @default.
• W2035732188 hasConcept C204243189 @default.
• W2035732188 hasConcept C23131810 @default.
• W2035732188 hasConcept C2776912625 @default.
• W2035732188 hasConcept C2779134260 @default.
• W2035732188 hasConcept C2779343474 @default.
• W2035732188 hasConcept C535046627 @default.
• W2035732188 hasConcept C71924100 @default.
• W2035732188 hasConcept C86803240 @default.
• W2035732188 hasConceptScore W2035732188C126322002 @default.
• W2035732188 hasConceptScore W2035732188C151730666 @default.
• W2035732188 hasConceptScore W2035732188C168563851 @default.
• W2035732188 hasConceptScore W2035732188C177713679 @default.
• W2035732188 hasConceptScore W2035732188C1862650 @default.
• W2035732188 hasConceptScore W2035732188C203092338 @default.
• W2035732188 hasConceptScore W2035732188C204243189 @default.
• W2035732188 hasConceptScore W2035732188C23131810 @default.
• W2035732188 hasConceptScore W2035732188C2776912625 @default.
• W2035732188 hasConceptScore W2035732188C2779134260 @default.
• W2035732188 hasConceptScore W2035732188C2779343474 @default.
• W2035732188 hasConceptScore W2035732188C535046627 @default.
• W2035732188 hasConceptScore W2035732188C71924100 @default.
• W2035732188 hasConceptScore W2035732188C86803240 @default.
• W2035732188 hasIssue "5" @default.
• W2035732188 hasLocation W20357321881 @default.
• W2035732188 hasLocation W20357321882 @default.
• W2035732188 hasOpenAccess W2035732188 @default.
• W2035732188 hasPrimaryLocation W20357321881 @default.
• W2035732188 hasRelatedWork W1906133657 @default.
• W2035732188 hasRelatedWork W2089908284 @default.
• W2035732188 hasRelatedWork W2094339332 @default.
• W2035732188 hasRelatedWork W2381765282 @default.
• W2035732188 hasRelatedWork W2799871749 @default.
• W2035732188 hasRelatedWork W3035658224 @default.
• W2035732188 hasRelatedWork W4205356977 @default.
• W2035732188 hasRelatedWork W4210484722 @default.
• W2035732188 hasRelatedWork W4306632388 @default.
• W2035732188 hasRelatedWork W2525720579 @default.
• W2035732188 hasVolume "13" @default.
• W2035732188 isParatext "false" @default.
• W2035732188 isRetracted "false" @default.
• W2035732188 magId "2035732188" @default.
• W2035732188 workType "article" @default.